Postpartum haemorrhage (PPH) is a major cause of maternal morbidity and mortality in Nepal. Compounded by the remote terrain, endemic poverty, and a lack of access to health facilities, the use of misoprostol has advantages over the standard use of oxytocin for PPH management. Drawing on our qualitative study of a pilot intervention managed by the Nepal Family Health Programme, we map the institutional relationships involved in the design, implementation, and practices for bringing misoprostol into national policy. In the intense and competitive global and national policy arena, sustained lobbying and getting the ‘right people’ on board were as powerful drivers as the quality of the intervention itself. The case study takes us to the hear...
Ndola Prata, Suzanne Bell, Karen Weidert Bixby Center for Population, Health and Sustainability, Sch...
We explored the feasibility of distributing misoprostol tablets using two strategies in prevention o...
AIMS: Evidence exists about prevention of postpartum haemorrhage (PPH) by oral administration of mis...
Postpartum haemorrhage (PPH) is a major cause of maternal morbidity and mortality in Nepal. Compound...
Abstract Background In 2009, the Nepal Ministry of Health and Population launched a national program...
Globally, significant progress has been made in reducing maternal mortality, yet in many low-resourc...
Misoprostol use for postpartum haemorrhage (PPH) has been promoted by Civil Society Organizations (C...
Background Globally, significant progress has been made in reducing maternal mortality, yet in many ...
BACKGROUND:Globally, significant progress has been made in reducing maternal mortality, yet in many ...
Purpose: The purpose of this study was to gather the necessary data to support the design and implem...
Postpartum Haemorrhage (PPH) is the most common cause of maternal mortality globally, leading to a w...
In developing countries-Post-partum hemorrhage (PPH) and abortion related complications remained to ...
AbstractThe lack of clear interpretation of clinical and operational evidence on misoprostol use for...
AbstractClinical and operational evidence indicates that misoprostol is a safe and effective technol...
Recent efforts to prevent post-partum haemorrhage (PPH) in low-income countries have focused on prov...
Ndola Prata, Suzanne Bell, Karen Weidert Bixby Center for Population, Health and Sustainability, Sch...
We explored the feasibility of distributing misoprostol tablets using two strategies in prevention o...
AIMS: Evidence exists about prevention of postpartum haemorrhage (PPH) by oral administration of mis...
Postpartum haemorrhage (PPH) is a major cause of maternal morbidity and mortality in Nepal. Compound...
Abstract Background In 2009, the Nepal Ministry of Health and Population launched a national program...
Globally, significant progress has been made in reducing maternal mortality, yet in many low-resourc...
Misoprostol use for postpartum haemorrhage (PPH) has been promoted by Civil Society Organizations (C...
Background Globally, significant progress has been made in reducing maternal mortality, yet in many ...
BACKGROUND:Globally, significant progress has been made in reducing maternal mortality, yet in many ...
Purpose: The purpose of this study was to gather the necessary data to support the design and implem...
Postpartum Haemorrhage (PPH) is the most common cause of maternal mortality globally, leading to a w...
In developing countries-Post-partum hemorrhage (PPH) and abortion related complications remained to ...
AbstractThe lack of clear interpretation of clinical and operational evidence on misoprostol use for...
AbstractClinical and operational evidence indicates that misoprostol is a safe and effective technol...
Recent efforts to prevent post-partum haemorrhage (PPH) in low-income countries have focused on prov...
Ndola Prata, Suzanne Bell, Karen Weidert Bixby Center for Population, Health and Sustainability, Sch...
We explored the feasibility of distributing misoprostol tablets using two strategies in prevention o...
AIMS: Evidence exists about prevention of postpartum haemorrhage (PPH) by oral administration of mis...